BioSpace News Archive

Full Results From Phase 2 ATLAS Study Support Potential for Combination Approaches for the Treatment of Patients With Advanced Fibrosis Due to NASH

West Nile virus belongs to the Flaviviridae family, comprising pestivirus, flavivirus, and hepacivirus.

Bioinformatics involves the development and application of novel informatics techniques in the field of biology. It improves the methods of storing, organizing, retrieving and analyzing biological data.

Dental Membrane and Bone Graft Substitutes Market: Collagen Becoming the Preferred Material of Choice

The global life science instrumentation market is projected to reach US$ 90 Bn by 2027, expanding at a single digit CAGR during the forecast period.

Heavy traffic, increasing urban population, and the rising demand for pre-hospital emergency services has catalyzed the need for motor ambulances.

IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced the issuance of U.S. Patent No. 10,687,720 B2 for “Automatic Air Management System.”

Alligator Bioscience will give status updates and details on the recent clinical development plans for the clinical drug candidates mitazalimab, ATOR-1015 and ATOR-1017 on a virtual R&D Day on August 27.

Morphic Therapeutic and AbbVie announced that AbbVie has exercised a license option under the companies’ research and development collaboration agreement to develop Morphic’s αvβ6 integrin inhibitors for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis and additional indications.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced that Company CEO Dwight Egan will be discussing the Company’s significant growth, profitability, and future objectives at H.C. Wainwright’s 22nd Annual Global Investment Conference on Monday, September 14th at 10:00 ET.